Australia, June 5 -- Amylyx Pharmaceuticals Inc., owns the trademark (2632805) for 'BAYLINZ' till Feb. 4, 2036.
Status: protected:
Registered/protected
Class: 5 [Pharmaceutical preparations for the treatment of endocrine, metabolic, and hormonal related diseases and disorders.]
Type of Mark: Word
Date of Acceptance: March 27
Registration Advertised: June 4
For further details contact Fish & Richardson P.C..
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2632805.
Disclaimer: Curated by HT Syndication.
